The therapeutic effect of memantine through the stimulation of synapse formation and dendritic spine maturation in autism and fragile X syndrome.

Although the pathogenic mechanisms that underlie autism are not well understood, there is evidence showing that metabotropic and ionotropic glutamate receptors are hyper-stimulated and the GABAergic system is hypo-stimulated in autism. Memantine is an uncompetitive antagonist of NMDA receptors and i...

Full description

Bibliographic Details
Main Authors: Hongen Wei, Carl Dobkin, Ashfaq M Sheikh, Mazhar Malik, W Ted Brown, Xiaohong Li
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3352866?pdf=render
_version_ 1828776619516362752
author Hongen Wei
Carl Dobkin
Ashfaq M Sheikh
Mazhar Malik
W Ted Brown
Xiaohong Li
author_facet Hongen Wei
Carl Dobkin
Ashfaq M Sheikh
Mazhar Malik
W Ted Brown
Xiaohong Li
author_sort Hongen Wei
collection DOAJ
description Although the pathogenic mechanisms that underlie autism are not well understood, there is evidence showing that metabotropic and ionotropic glutamate receptors are hyper-stimulated and the GABAergic system is hypo-stimulated in autism. Memantine is an uncompetitive antagonist of NMDA receptors and is widely prescribed for treatment of Alzheimer's disease treatment. Recently, it has been shown to improve language function, social behavior, and self-stimulatory behaviors of some autistic subjects. However the mechanism by which memantine exerts its effect remains to be elucidated. In this study, we used cultured cerebellar granule cells (CGCs) from Fmr1 knockout (KO) mice, a mouse model for fragile X syndrome (FXS) and syndromic autism, to examine the effects of memantine on dendritic spine development and synapse formation. Our results show that the maturation of dendritic spines is delayed in Fmr1-KO CGCs. We also detected reduced excitatory synapse formation in Fmr1-KO CGCs. Memantine treatment of Fmr1-KO CGCs promoted cell adhesion properties. Memantine also stimulated the development of mushroom-shaped mature dendritic spines and restored dendritic spine to normal levels in Fmr1-KO CGCs. Furthermore, we demonstrated that memantine treatment promoted synapse formation and restored the excitatory synapses to a normal range in Fmr1-KO CGCs. These findings suggest that memantine may exert its therapeutic capacity through a stimulatory effect on dendritic spine maturation and excitatory synapse formation, as well as promoting adhesion of CGCs.
first_indexed 2024-12-11T16:02:51Z
format Article
id doaj.art-94b44170c4764261b7e4a77f2a7a55c1
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-11T16:02:51Z
publishDate 2012-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-94b44170c4764261b7e4a77f2a7a55c12022-12-22T00:59:16ZengPublic Library of Science (PLoS)PLoS ONE1932-62032012-01-0175e3698110.1371/journal.pone.0036981The therapeutic effect of memantine through the stimulation of synapse formation and dendritic spine maturation in autism and fragile X syndrome.Hongen WeiCarl DobkinAshfaq M SheikhMazhar MalikW Ted BrownXiaohong LiAlthough the pathogenic mechanisms that underlie autism are not well understood, there is evidence showing that metabotropic and ionotropic glutamate receptors are hyper-stimulated and the GABAergic system is hypo-stimulated in autism. Memantine is an uncompetitive antagonist of NMDA receptors and is widely prescribed for treatment of Alzheimer's disease treatment. Recently, it has been shown to improve language function, social behavior, and self-stimulatory behaviors of some autistic subjects. However the mechanism by which memantine exerts its effect remains to be elucidated. In this study, we used cultured cerebellar granule cells (CGCs) from Fmr1 knockout (KO) mice, a mouse model for fragile X syndrome (FXS) and syndromic autism, to examine the effects of memantine on dendritic spine development and synapse formation. Our results show that the maturation of dendritic spines is delayed in Fmr1-KO CGCs. We also detected reduced excitatory synapse formation in Fmr1-KO CGCs. Memantine treatment of Fmr1-KO CGCs promoted cell adhesion properties. Memantine also stimulated the development of mushroom-shaped mature dendritic spines and restored dendritic spine to normal levels in Fmr1-KO CGCs. Furthermore, we demonstrated that memantine treatment promoted synapse formation and restored the excitatory synapses to a normal range in Fmr1-KO CGCs. These findings suggest that memantine may exert its therapeutic capacity through a stimulatory effect on dendritic spine maturation and excitatory synapse formation, as well as promoting adhesion of CGCs.http://europepmc.org/articles/PMC3352866?pdf=render
spellingShingle Hongen Wei
Carl Dobkin
Ashfaq M Sheikh
Mazhar Malik
W Ted Brown
Xiaohong Li
The therapeutic effect of memantine through the stimulation of synapse formation and dendritic spine maturation in autism and fragile X syndrome.
PLoS ONE
title The therapeutic effect of memantine through the stimulation of synapse formation and dendritic spine maturation in autism and fragile X syndrome.
title_full The therapeutic effect of memantine through the stimulation of synapse formation and dendritic spine maturation in autism and fragile X syndrome.
title_fullStr The therapeutic effect of memantine through the stimulation of synapse formation and dendritic spine maturation in autism and fragile X syndrome.
title_full_unstemmed The therapeutic effect of memantine through the stimulation of synapse formation and dendritic spine maturation in autism and fragile X syndrome.
title_short The therapeutic effect of memantine through the stimulation of synapse formation and dendritic spine maturation in autism and fragile X syndrome.
title_sort therapeutic effect of memantine through the stimulation of synapse formation and dendritic spine maturation in autism and fragile x syndrome
url http://europepmc.org/articles/PMC3352866?pdf=render
work_keys_str_mv AT hongenwei thetherapeuticeffectofmemantinethroughthestimulationofsynapseformationanddendriticspinematurationinautismandfragilexsyndrome
AT carldobkin thetherapeuticeffectofmemantinethroughthestimulationofsynapseformationanddendriticspinematurationinautismandfragilexsyndrome
AT ashfaqmsheikh thetherapeuticeffectofmemantinethroughthestimulationofsynapseformationanddendriticspinematurationinautismandfragilexsyndrome
AT mazharmalik thetherapeuticeffectofmemantinethroughthestimulationofsynapseformationanddendriticspinematurationinautismandfragilexsyndrome
AT wtedbrown thetherapeuticeffectofmemantinethroughthestimulationofsynapseformationanddendriticspinematurationinautismandfragilexsyndrome
AT xiaohongli thetherapeuticeffectofmemantinethroughthestimulationofsynapseformationanddendriticspinematurationinautismandfragilexsyndrome
AT hongenwei therapeuticeffectofmemantinethroughthestimulationofsynapseformationanddendriticspinematurationinautismandfragilexsyndrome
AT carldobkin therapeuticeffectofmemantinethroughthestimulationofsynapseformationanddendriticspinematurationinautismandfragilexsyndrome
AT ashfaqmsheikh therapeuticeffectofmemantinethroughthestimulationofsynapseformationanddendriticspinematurationinautismandfragilexsyndrome
AT mazharmalik therapeuticeffectofmemantinethroughthestimulationofsynapseformationanddendriticspinematurationinautismandfragilexsyndrome
AT wtedbrown therapeuticeffectofmemantinethroughthestimulationofsynapseformationanddendriticspinematurationinautismandfragilexsyndrome
AT xiaohongli therapeuticeffectofmemantinethroughthestimulationofsynapseformationanddendriticspinematurationinautismandfragilexsyndrome